Objective:To evaluate the effectiveness of mother's breast milk odor on alleviating operational pain in newborns.Methods:The randomized controlled trial on the effect of mother's breast milk odor in operational pain of newborns was searched through computers in PubMed, Embase, Cochrane Library, Web of Science, CINAHL, China National Knowledge Infrastructure (CNKI) and Wanfang Data. The search period was from database establishment to December 12, 2022. Two evaluators independently selected literature and extracted data based on the inclusion and exclusion criteria, and used the risk of bias of Cochrane Collaboration handbook to conduct methodological quality evaluations of the included study. R 4.1.0 statistical software was used for meta-analysis.Results:A total of 18 articles were included, including 1 424 newborns. The Meta-analysis results showed that compared with the control group, the mother's breast milk odor group showed a decrease in the degree of pain, a decrease in heart rate, and an increase in blood oxygen saturation during the painful procedure in newborns, with statistically significant differences ( P<0.05) . There was no statistically significant difference in crying time ( P>0.05) . Compared with the control group, the mother's breast milk odor group showed a statistically significant decrease in the degree of pain and heart rate, an increase in blood oxygen saturation, and a decrease in salivary cortisol in newborns during the recovery period after painful procedures ( P<0.05) . Conclusions:The mother's breast milk odor can alleviate operational pain in newborns, reduce heart rate and salivary cortisol, and increase blood oxygen saturation in newborns. The sample size included in the study is small, and there are also differences in the duration and methods of intervention among different studies. There is still a need for rigorous design and large-scale research to verify.

Objective:To summarize the best evidence of transitional care for adolescents with systemic lupus erythematosus, and provide reference for clinical implementation of transitional care.Methods:According to the "6S" evidence pyramid model, the guide websites, related association websites and databases at home and abroad were searched from the establishment of the databases to November 7, 2023. The quality of literature was evaluated independently by two researchers. The evidence was graded according to the evidence grading and recommendation grading system of the Joanna Briggs Institute Evidence-Based Health Care Center.Results:A total of 20 articles were included, including one clinical decision, one guideline, 16 expert consensus and two systematic evaluations. A total of 27 best pieces of evidence were extracted from five aspects, including transition principles, formation of transition teams, initiation of transition, individualized care during the transition period and transferring to the adult health care system.Conclusions:This study summarizes the best evidence on transitional care for adolescent patients with systemic lupus erythematosus. Medical staff can refer to the evidence and combine hospital policies, patients' own conditions and the wishes of patients and parents to develop personalized transitional care plans to help patients transition smoothly and improve their outcomes after transfer.

Objective:To compare the diagnostic efficacy of 22 G fine needle aspiration (FNA) needles and 22 G end-cutting fine needle biopsy (FNB) needles for solid pancreatic lesion using both cytological and histological examination.Methods:Clinical data of 116 patients who underwent endoscopic ultrasound-guided fine needle aspiration/biopsy (EUS-FNA/FNB) at the Digestive Endoscopy Center of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from June 2022 to March 2023 were retrospectively analyzed. Sixty-three patients sampled with 22 G FNA needles were the FNA group, and 53 sampled with 22 G FNB needles were the FNB group. The diagnostic accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and cytological and histological diagnostic yield of FNA needles and FNB needles for solid pancreatic lesions were compared.Results:There were no significant differences in age, gender, lesion location, lesion size, or the number of passes between the FNA group and the FNB group ( P>0.05). There were no significant differences in the diagnostic accuracy [93.7% (59/63) VS 90.6% (48/53), P=0.730], sensitivity [93.0% (53/57) VS 90.2% (46/51), P=0.732], specificity [100.0% (6/6) VS 100.0% (2/2), P=1.000], positive predictive value [100.0% (53/53) VS 100.0% (46/46), P=1.000] and negative predictive value [60.0% (6/10) VS 28.6% (2/7), P=0.335] of combined cytology and histology in distinguishing benign and malignant lesions between the two groups. In the FNA group, the diagnostic accuracy of combined cytology and histology was higher than cytology alone [93.7% (59/63) VS 81.0% (51/63), P=0.008], and was higher than histology alone without statistical significance [93.7% (59/63) VS 87.3% (55/63), P=0.125]. In the FNB group, the diagnostic accuracy of combined cytology and histology was higher than cytology alone [90.6% (48/53) VS 69.8% (37/53), P=0.001], but not than histology alone [90.6% (48/53) VS 90.6% (48/53)， P=1.000]. For solid masses located in pancreatic body/tail, the diagnostic accuracy for malignancy by histology using FNB needles tended to be higher than that of FNA needles [100.0% (17/17) VS 81.3% (26/32), P=0.080]. Conclusion:Both FNA needles and FNB needles exhibit adequate diagnostic yield for solid pancreatic masses when combining cytology and histology. FNB needles may offer a higher histological diagnostic yield.

Objective Oxidative stress (OS) plays a crucial role in ischemic stroke. Grape seed procyanidin extract (GSPE) was reported to be a critical regulator of OS. We hypothesized that GSPE might also be protective in ischemia-reperfusion brain injury. This study aimed to explore whether GSPE administration can protect mice from ischemia-reperfusion brain injury.Methods Transient middle cerebral artery occlusion (MCAO) was conducted followed by reperfusion for 24 hours to make ischemia-reperfusion brain injury in mice that received GSPE (MCAOG, n=60) or normal saline (MCAONS, n=60). Sham-operated mice (GSPE group and normal saline group) were set as controls. The neurological severity score (NSS) was used to evaluate neural function impairment 1 hour, 24 hour, 3 days and 7 days after MCAO. Mice underwent brain T2WI imaging with a 3T animal MRI scanner 24 hours after reperfusion, and the stroke volume of brains were calculated according to abnormal signal intensity. Immunohistopathological analysis of brain tissues at 24 h after reperfusion was performed for neuronal nuclear antigen (NeuN), CD34, Bcl-2, and Bax. Glutathione peroxidation (GSH-Px) activity and the level of malonaldehyde (MDA) of brain tissue were also examined. The above indexes were compared among the groups statistically.Results Significant functional improvement was observed 24 hours after MCAO in MCAOG group compared to MCAONS group (P<0.05). MCAOG group had smaller cerebral stroke volume (22.46 ± 11.45 mmvs. 47.84±9.06 mm, P<0.05) than MCAONS group 24 hours after MCAO. More mature NeuN-immunoreactive neurons and more CD34-positive cells in peri-infarct zones were observed in brain tissue of MCAOG mice 24 h after MCAO than that of MCAONS mice (both P<0.05). MCAONS mice had significantly higher number of Bax-positive cells in brain tissue than MCAOG (P<0.05). The mean MDA level was significantly lower (P<0.05) and the GSH-Px activity was significantly higher (P<0.05) in brains of MCAOG mice compared to those of MCAONS mice.Conclusion GSPE administration protects mice from ischemia-reperfusion brain injury through attenuating oxidative stress and apoptosis, promoting angiogenesis, and activating antioxidant enzyme GSH-Px. GSPE may represent a new therapeutical direction for the treatment of ischemia-reperfusion brain injury.
Animals ; Apoptosis ; drug effects ; Brain ; blood supply ; Glutathione Peroxidase ; metabolism ; Grape Seed Extract ; pharmacology ; Infarction, Middle Cerebral Artery ; Male ; Mice ; Mice, Inbred C57BL ; Neuroprotective Agents ; pharmacology ; Oxidative Stress ; Proanthocyanidins ; pharmacology ; Reperfusion Injury ; drug therapy ; metabolism